83
22
Growth Score 83 in past quarter
-1 pts
Heat Score 22 in past quarter
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
406429
Genetic Leap uses AI for precise gene control with RNA-targeted molecules to treat diseases.
- David Young: CFO
- Bertrand Adanve: Founder & CEO
About the Company
Genetic Leap focuses on AI-driven solutions for precise and durable control of gene expression using RNA-targeted molecules. The company aims to address intractable diseases by leveraging gene therapy and epigenetic drug development. Their portfolio includes both internal and partnered programs targeting novel and known disease mechanisms. Genetic
Leap's multidisciplinary team combines expertise in biology, chemistry, and AI to advance healthcare innovations.